Dolby Laboratories (NYSE:DLB) Issues Q2 2025 Earnings Guidance

Dolby Laboratories (NYSE:DLB) issued an update on its second quarter 2025 earnings guidance on Wednesday morning. The company provided earnings per share guidance of 1.190-1.340 for the period, compared to the consensus earnings per share estimate of 1.350. The company issued revenue guidance of $355.0 million-$385.0 million, compared to the consensus revenue estimate of $387.2 million. Dolby Laboratories also updated its FY 2025 guidance to 3.990-4.140 EPS.

Dolby Laboratories Trading Up 8.2 %

Shares of Dolby Laboratories stock opened at $87.20 on Friday. Dolby Laboratories has a 12 month low of $66.35 and a 12 month high of $89.66. The company has a market capitalization of $8.32 billion, a PE ratio of 32.06 and a beta of 0.98. The stock’s fifty day simple moving average is $79.29 and its 200 day simple moving average is $75.73.

Dolby Laboratories Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, February 19th. Stockholders of record on Tuesday, February 11th will be issued a dividend of $0.33 per share. This represents a $1.32 annualized dividend and a dividend yield of 1.51%. The ex-dividend date is Tuesday, February 11th. Dolby Laboratories’s dividend payout ratio (DPR) is presently 48.53%.

Analysts Set New Price Targets

A number of analysts recently issued reports on DLB shares. Rosenblatt Securities reissued a “buy” rating and set a $100.00 target price on shares of Dolby Laboratories in a research note on Thursday. StockNews.com raised shares of Dolby Laboratories from a “buy” rating to a “strong-buy” rating in a research report on Wednesday, December 4th. Finally, Barrington Research reaffirmed an “outperform” rating and issued a $100.00 price objective on shares of Dolby Laboratories in a research report on Monday.

Insider Activity at Dolby Laboratories

In other news, Director Peter C. Gotcher sold 6,079 shares of Dolby Laboratories stock in a transaction that occurred on Thursday, November 21st. The shares were sold at an average price of $78.96, for a total value of $479,997.84. Following the sale, the director now directly owns 37,593 shares in the company, valued at $2,968,343.28. This trade represents a 13.92 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Mark Andrew Sherman sold 12,338 shares of the business’s stock in a transaction on Tuesday, December 17th. The stock was sold at an average price of $78.08, for a total transaction of $963,351.04. Following the completion of the sale, the executive vice president now directly owns 62,397 shares in the company, valued at approximately $4,871,957.76. This represents a 16.51 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 135,917 shares of company stock valued at $10,877,739. 38.39% of the stock is owned by insiders.

Dolby Laboratories Company Profile

Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.